Search all trials

Find therapies in clinical trials near you – page 44

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer+17

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atl001

Contact Research Centre

Marginal zone lymphoma

Not recruiting

Registered drugNo placebo

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Ovarian cancer

Not recruiting

Registered drugNo placebo

Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Brimonidine Tartrate

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 44

648 trials match your criteria

Non-small cell lung cancer+17

Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Marginal zone lymphoma

Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Bladder cancer

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Non-small cell lung cancer

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

B-cell small lymphocytic lymphoma

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Ovarian cancer

Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

Myelodysplastic syndrome

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Hormone receptor positive HER2 negative breast cancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Prostate cancer metastatic

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Dermatitis atopic

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Transitional cell carcinoma

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.